← All thesesTEUnattractiveMedium convictionFriday 13 November 2026עברית

T1 Energy

This is the archived full research. Read the story

A Texas factory that assembles solar panels for large solar farms, bought from China's Trina Solar in 2024, and now building its own cell plant.

Our viewUnattractive Medium conviction
The scores
The profile · 1-4
Growth1/4 ↑

Sales rose 88% in Q2, but all of 2026's went to Trina, a related party, and gross profit exists only with the credit.

Business quality2/4 →

Module assembly is widely copied; the edge is a credit and a floor that Qcells and First Solar already earn with American cells.

Financial position2/4 ↓

G2 needs $200M-$250M not yet raised, bridged by convertible notes; operations used $103M in the half.

Execution record2/4 ↓

Plant cost up to $510M, first cells pushed to 2027, financing slipped four times, controls weakness unremediated.

Per share capture1/4 ↓

Shares nearly doubled in a year; patents paid in discounted stock, notes convert at $4.46, and new financing may rank ahead.

Potential2/4 →

A large US market and a price floor, but the payoff needs G2 built, financed and the credit kept, two outside T1's control.

Risk profile2/4 →

One external ruling decides the credit that is the profit; Trina is sole customer and main supplier; DOJ and patent suits pending.

Valuation3/4 ↑

About 2.8 to 3.4 times guided 2027 EBITDA prices the plan only partly working, but that EBITDA is the credit.

Evidence quality2/4 →

Figures are filed, but the credit's eligibility, what Trina supplied and the contract prices are unverifiable from outside.

The bet · 2-3 years
Priced for success1.3×

If it works 1.3× · if it fails you keep about 0%.

The Verdict

We rate T1 Energy Unattractive. It assembles solar panels in Texas, and nearly all its sales still go to Trina, the Chinese company that sold it the factory. Its profit is a US tax credit denied to companies too close to Chinese firms, under rules not yet written, and it has not sold any of this year's credits; without the credit the latest quarter lost money. The cell plant still waits for its loan and bonds convert into shares, so the business is weak. The price pays for that credit arriving. As a bet it is fragile: about today's money if it works, little or nothing if it fails.

The long caseAmerica keeps building large solar farms, and trade and tax rules reward panels made at home, so a Texas factory can sell what it makes, if its tax credit holds.

How we weighed it

The price against our value

Cuts both ways

No fair value is drawn: the forecasts show no lasting profit after stock pay, so the bet prices it.

The business

Against it

Weak

A weak business: its profit is a tax credit.

Growth against what the price assumes

Against it

One related company took all of this year's sales.

What could go wrong

Against it

The credit could be denied, the SEC is investigating what the company said about qualifying for it, and more shares are coming.

Against competitors

Cuts both ways

Its rivals are profitable and it is not.

How its group is behaving

Cuts both ways

Power names move together on AI power news; it ranks last in its group.

The latest news and report

Against it

The latest report sold no credits and closed no financing, and slowed the cell plant to wait for money; new contracts for next year are the one gain.

The evidence under this - 9 claims
C01facthigh confidence
T1 Energy assembles solar modules at G1_Dallas in Wilmer, Texas, a 5 GW-a-year plant it bought from Trina Solar in December 2024, from solar cells it buys; it began building a 2.1 GW first phase of its own cell plant, G2_Austin, in December 2025.
current state · 2026-06-30written 2026-09-29
C02facthigh confidence
One customer took about 100% of T1's net sales in the first half of 2026 and all trade receivables; the 10-Q reports $450.2M of gross module sales to the Trina Group in that half, presented as related-party sales.
historical · H1 2026written 2026-09-29
C59estimatemedium confidence
In Q3 2026 T1 made 1,056 MW of modules and added 326 MW to stock, so about 730 MW shipped; net sales were $196.6M, $189.9M to the Trina Group, and gross profit $16.7M with no tariff refund. Take out the credit at 7 cents on about 730 MW (about $51M) and the quarter was a gross loss near $34M, on revenue near 26 cents a watt.
against this
  • Shipped volume is derived from production less the inventory build; T1 does not state MW sold.
  • Management attributes the margin to facility costs of building stock, and quotes higher prices for 2027 contracts (C60).
historical · Q3 2026written 2026-11-12
C09management claimlow confidence
Management guides to adjusted EBITDA at an annual run-rate of $375M to $450M once 5 GW of G1 modules run with 2.1 GW of G2 cells, and $650M to $700M with 5 GW of each; the Q3 deck of 12 November reaffirmed both unchanged.
against this
  • The same release that set it (March 2026) put first cells in Q4 2026 and G2 financial close early in Q2; both slipped (C17, C18).
  • Q2 2026 adjusted EBITDA excluding the tariff refund was about -$13.7M (C05).
  • Q3 2026 adjusted EBITDA was -$16.4M, and G2 spending is now paced to a financing not yet closed (C17, C18).
  1. 2026-11-12editedreaffirmed unchanged in the Q3 deck
forwardwritten 2026-09-29
C10estimatemedium confidence
At the guided scale the Section 45X credit alone is about $434M a year, 5 GW of modules at 7 cents plus 2.1 GW of cells at 4 cents: more than the $412M midpoint of the adjusted EBITDA guide.
derived5,000 MW x $0.07 = $350M plus 2,100 MW x $0.04 = $84M (C06, C07) against the $375M-$450M guide (C09).
against this
  • The guide may assume higher module prices after the 4 December floor, so profit before credits need not be negative (C25).
  • Not every watt made is sold to a third party within the year, which is when the credit is earned.
forwardwritten 2026-09-29
C12management claimlow confidence
T1 says the February guidance validates its compliance plan and that it expects to be eligible for 45X; it bought cells for part of 2026 output from suppliers certifying non-PFE status, and in November 2026 said third-party diligence put about 65% of its cell supply-chain material through Q2 outside foreign entities of concern, above the 50% safe-harbour ratio.
against this
  • The notice it cites left ownership and effective control, which its restructuring addressed, to future guidance (C11).
  • A short seller alleges $65M of Trina cell purchases in Q1 2026 (C15); the 10-Q shows $428.1M bought from the Trina Group in the half without naming the goods (C03).
  • The SEC opened an investigation in September 2026 into T1's public disclosures on its 45X eligibility (C62).
  1. 2026-11-12editedthe Q3 release adds management's figure of about 65% non-foreign-entity material through Q2
  2. 2026-11-13editedthe SEC's investigation into T1's 45X-eligibility disclosures (C62) is new counter-evidence to management's eligibility claim
current state · 2026-11-12written 2026-09-29
C39facthigh confidence
T1 sold its 2025 credits for cash: $160M at $0.91 in December 2025 and the last $39.1M at $0.93 in June 2026. By 12 November 2026 it had sold none of the $155.3M of 2026 credits generated through Q3, reporting only that several conversations had advanced; on the call the CFO said the tax-equity market had been slow to develop this year, particularly for non-investment-grade sellers. Government grants receivable were $139.1M at 30 September.
  1. 2026-11-12editedthe Q3 release reports no 2026 credit sale, $155.3M generated and grants receivable of $139.1M
  2. 2026-11-12editedthe Q3 call: the CFO says the tax-equity market has been slow for non-investment-grade sellers
current state · 2026-11-12written 2026-09-29
C17facthigh confidence
G2_Austin's first phase now costs $510M, from $400M-$425M in March, and first cells moved from Q4 2026 to Q1 2027; the company blames tight Texas data-centre construction. By November the steel was up, all Phase 1 tools were at US ports and MEP work had begun, but T1 matched capital spending to the timing of the unclosed financing. On the 12 November call management moved first production from March towards April 2027 and said that, assuming financial close by year-end, construction, commissioning and ramp would finish by about mid-2027.
  1. 2026-11-12editedthe Q3 release: construction progress, spending paced to the financing, no first-cell date given
  2. 2026-11-12editedthe Q3 call gives a conditional first-cell date: towards April 2027, ramped by mid-2027 if the financing closes by year-end
current state · 2026-11-12written 2026-09-29
C18facthigh confidence
In March T1 targeted G2's full financing early in Q2 2026; on the August call an analyst noted it had slipped from May to June to July. On 12 November it was still unclosed: T1 is in exclusive negotiations with institutional investors for a mainly debt financing that 'may include or require' new equity or equity-linked securities, bridged by $120M of convertible notes in July and $50M more on 30 September.
  1. 2026-11-12editedthe Q3 release: financing still unclosed, exclusive talks for a mainly debt package that may include equity
current state · 2026-11-12written 2026-09-29
01

The company

T1 makes the large glass panels used on solar farms. Its factory near Dallas takes solar cells, the thin silicon wafers that turn light into electricity, wires them into rows and seals them between glass. It can make 5 gigawatts of panels a year.

Buyers are developers building solar farms. They could buy imported panels, or American panels from dozens of other assemblers. What sets panels apart now is less the product than the tax rules around where its parts came from.

The evidence under this - 4 claims
C01facthigh confidence
T1 Energy assembles solar modules at G1_Dallas in Wilmer, Texas, a 5 GW-a-year plant it bought from Trina Solar in December 2024, from solar cells it buys; it began building a 2.1 GW first phase of its own cell plant, G2_Austin, in December 2025.
current state · 2026-06-30written 2026-09-29
C26factmedium confidence
America had 69.9 GW of module capacity and about 3 GW of cell capacity in mid-2026, so almost every American-assembled silicon module uses an imported cell.
current state · 2026-06-30written 2026-09-29
C30facthigh confidence
T1's 10-K names First Solar, Canadian Solar, JinkoSolar and Hanwha Qcells as its largest US competitors, and says only First Solar and Qcells already make significant cell volumes in America.
current state · 2026-03-31written 2026-09-29
C06facthigh confidence
Section 45X pays 4 cents a watt for a solar cell and 7 cents for a module made in America, falling to 75% in 2030, 50% in 2031, 25% in 2032 and nil after; a specified or foreign-influenced entity, or a component with material assistance from a prohibited foreign entity, gets none.
current state · 2025-07-04written 2026-09-29

How it makes money

T1 sells panels by the watt, about 30 cents each in the second quarter of 2026, and customers prepay half before each quarter.

On top, the government pays 7 cents for every watt of panel made in America and sold, through a credit T1 sells to financial buyers for cash. That credit, not the panel price, is what turns a loss into a profit.

The evidence under this - 4 claims
C05facthigh confidence
In Q2 2026 T1 made 935 MW of modules and reported net sales of $250.1M, gross profit of $49.1M including $24.4M of refunded tariffs, an operating loss of $22.8M and adjusted EBITDA of $10.7M including the refund.
historical · Q2 2026written 2026-09-29
C07management claimmedium confidence
T1 expects about 7 cents a watt of Section 45X credit on each module made in America and sold to a third party, and books the credit as a reduction of cost of sales.
against this

The credit is lost entirely if T1 is a specified or foreign-influenced entity, or if the materials in a module fail the material-assistance test (C06, C11).

forwardwritten 2026-09-29
C02facthigh confidence
One customer took about 100% of T1's net sales in the first half of 2026 and all trade receivables; the 10-Q reports $450.2M of gross module sales to the Trina Group in that half, presented as related-party sales.
historical · H1 2026written 2026-09-29
C23facthigh confidence
At 30 June 2026 T1 had contracts for 5.4 GW of future module sales: 1.5 GW in the rest of 2026, 1.3 GW in 2027 and 2.6 GW through 2029, with half the price prepaid before each quarter; the 3 GW of 2026 is cost-plus or fixed-margin.
current state · 2026-06-30written 2026-09-29
Where the money comes from, stream by stream
StreamShare of sales (H1 2026)How it earns it
Modules sold to the Trina Group (related party)99.9%Solar modules assembled at G1_Dallas and sold to Trina, which resells them to US developers as agent for a commission.
Modules sold to other buyers0.1%Modules sold directly to US developers; 22.3% of 2025 sales, before 2026 output went to Trina.

Who runs it

Daniel Barcelo, whose investment vehicle took the company public in 2021, has run it since late 2024. Insiders own about a fifth, almost all one investment fund's stake held by a director; the chief executive owns under 1%. Half his yearly bonus rides on company goals the company does not publish, half on the board's judgement, and his shares simply vest with time, not with results.

The evidence under this - 3 claims
C54facthigh confidence
Daniel Barcelo, a director since the 2021 SPAC merger his Alussa Energy sponsored, has been chief executive since November 2024 and chairman; Joseph Evan Calio, a former energy banker and analyst, has been CFO since June 2024; Jaime Gualy COO since August 2025.
current state · 2026-05-18written 2026-10-04
C55facthigh confidence
At the 8 May 2026 record date directors and officers held 22.44% of 279.1M shares, almost all through director Todd Kantor's Encompass Capital (19.99%, capped by a conversion blocker); Trina held 17.97% and BlackRock 5.3%; the chief executive held about 1.1M shares, under 1%.
against this

Trina sold 22.5M shares on 21-22 May 2026, after the record date (C16), so its stake is now smaller than the table shows.

current state · 2026-05-08written 2026-10-04
C56facthigh confidence
The 2025 cash bonus weighted undisclosed company goals and individual goals equally and paid the CEO $420K and $800K on them; long-term awards are stock options and time-vesting RSUs with no performance condition, plus January 2025 'transaction bonus' RSUs of 1.0M to the CEO and 1.5M to the CFO.
historical · FY2025written 2026-10-04
02

Why it wins, and who could beat it

Why customers come back

The advantage is the law. The credit pays American makers per watt, and from 4 December imported panels and cells must pay a minimum price plus a 15% duty.

That is why buyers have signed for panels from a cell plant that does not yet run. But the same floor charges T1 on the cells it still imports, until its own plant starts.

The evidence under this - 4 claims
C06facthigh confidence
Section 45X pays 4 cents a watt for a solar cell and 7 cents for a module made in America, falling to 75% in 2030, 50% in 2031, 25% in 2032 and nil after; a specified or foreign-influenced entity, or a component with material assistance from a prohibited foreign entity, gets none.
current state · 2025-07-04written 2026-09-29
C25facthigh confidence
From 4 December 2026 an imported solar cell may not enter below $0.22 a watt and a module below $0.38, plus a 15% duty; Commerce may grant tariff offsets to companies building US cell or wafer plants, and rescind them.
current state · 2026-08-11written 2026-09-29
C23facthigh confidence
At 30 June 2026 T1 had contracts for 5.4 GW of future module sales: 1.5 GW in the rest of 2026, 1.3 GW in 2027 and 2.6 GW through 2029, with half the price prepaid before each quarter; the 3 GW of 2026 is cost-plus or fixed-margin.
current state · 2026-06-30written 2026-09-29
C24factmedium confidence
Treaty Oak signed in December 2025 for at least 900 MW over three years, and Clearway in August 2026 for 641 MW, both of modules using G2_Austin cells; neither price nor delivery schedule is disclosed.
current state · 2026-08-12written 2026-09-29

The threat

Two rivals already have what T1 is building. Qcells makes American cells in Georgia, and First Solar makes panels that need no silicon cells at all. First Solar is also suing T1, saying the cells it imports copy a First Solar patent.

The evidence under this - 3 claims
C29factmedium confidence
Qcells began making cells at Cartersville, Georgia in June 2026 and says the site will make 3.3 GW each of ingots, wafers and cells a year by Q3 2026.
current state · 2026-06-17written 2026-09-29
C30facthigh confidence
T1's 10-K names First Solar, Canadian Solar, JinkoSolar and Hanwha Qcells as its largest US competitors, and says only First Solar and Qcells already make significant cell volumes in America.
current state · 2026-03-31written 2026-09-29
C31facthigh confidence
First Solar sued T1 for infringing a TOPCon cell patent; the trade-commission complaint it joined is being withdrawn, and the district-court suit continues.
current state · 2026-09-15written 2026-09-29

The rivals: FSLR, JKS, CSIQ, and 1 more that is private, in-house or listed abroad.

Who else does this, rival by rival
TickerRivalWhere it competesHow far alongPriced against it
Qcells (Hanwha Solutions), Cartersville, GeorgiaPriced against it: Listed abroadG2_Austin solar cell fab (Phase 1, 2.1 GW)On saleListed abroad
FSLRFirst SolarPriced against it: YesG1_Dallas solar module manufacturingOn saleYes
JKSJinkoSolar HoldingPriced against it: Yes-On saleYes
CSIQCanadian SolarPriced against it: Yes-On saleYes
03

How big it could get

How big this could get

America plans 43.4 gigawatts of large solar farms in 2026, 40% in Texas. At the new import floor of 38 cents a watt, that is about $16.5B of panels a year.

T1 made 935 megawatts in the second quarter, against 9.6 gigawatts installed nationally: about a tenth.

The evidence under this - 4 claims
C27facthigh confidence
The EIA says developers plan 43.4 GW of US utility-scale solar in 2026, 40% of it in Texas.
current state · 2026-02-20written 2026-09-29
C28factmedium confidence
US utility-scale solar installations were 9.6 GWdc in Q2 2026, up 61% on a year earlier, per SEIA.
historical · Q2 2026written 2026-09-29
C05facthigh confidence
In Q2 2026 T1 made 935 MW of modules and reported net sales of $250.1M, gross profit of $49.1M including $24.4M of refunded tariffs, an operating loss of $22.8M and adjusted EBITDA of $10.7M including the refund.
historical · Q2 2026written 2026-09-29
C25facthigh confidence
From 4 December 2026 an imported solar cell may not enter below $0.22 a watt and a module below $0.38, plus a 15% duty; Commerce may grant tariff offsets to companies building US cell or wafer plants, and rescind them.
current state · 2026-08-11written 2026-09-29

Who has signed

T1 had 5.4 gigawatts under contract to 2029, most of it with Trina. Two American developers, Treaty Oak and Clearway, signed for 1.5 gigawatts of panels using T1's own future cells. Neither price nor delivery dates are public.

The evidence under this - 3 claims
C23facthigh confidence
At 30 June 2026 T1 had contracts for 5.4 GW of future module sales: 1.5 GW in the rest of 2026, 1.3 GW in 2027 and 2.6 GW through 2029, with half the price prepaid before each quarter; the 3 GW of 2026 is cost-plus or fixed-margin.
current state · 2026-06-30written 2026-09-29
C24factmedium confidence
Treaty Oak signed in December 2025 for at least 900 MW over three years, and Clearway in August 2026 for 641 MW, both of modules using G2_Austin cells; neither price nor delivery schedule is disclosed.
current state · 2026-08-12written 2026-09-29
C02facthigh confidence
One customer took about 100% of T1's net sales in the first half of 2026 and all trade receivables; the 10-Q reports $450.2M of gross module sales to the Trina Group in that half, presented as related-party sales.
historical · H1 2026written 2026-09-29
04

The results

The numbers

Is it growing?Fast

Sales grew 256× in the year to Dec 2025.

Dec 2023: $0Dec 2024: $2.94MDec 2025: $755M$0$755M
Is it profitable?Losing

Operating margin is −31%.

Dec 2024: −27×Dec 2025: −31%−27×−31%
Does growth pay off?Unclear

Running costs take 38¢ of each sales dollar, down from 2727¢ in the year to Dec 2024.

Dec 2024: 2727¢Dec 2025: 38¢2727¢38¢
Does it earn good returns?Poor

Shareholders' money lost 168% a year, down from −12% in the year to Dec 2023.

Dec 2023: −12%Dec 2024: −110%Dec 2025: −168%−12%−168%
Is it making cash?Thin

It turned 2.2% of sales into free cash, $16.7M over the year.

Dec 2023: −$276MDec 2024: −$154MDec 2025: $16.7M−$276M$16.7M
Is the balance sheet safe?Heavy debt

It owes $208M more than the cash it holds, about 2.2 years of the cash its operations bring in.

Dec 2023: $253MDec 2024: −$530MDec 2025: −$208M$253M−$208M
Are shares being diluted?Diluting

The share count rose 24% in 2.0 years, and pay in shares costs 1.5% of sales.

Dec 2023: 140MDec 2024: 141MDec 2025: 174M140M174M
All the numbers

Filed figures from the company's 10-K and 10-Q, read 2026-11-12. Fiscal years end in December.

Dec 2023Dec 2024Dec 2025
Size and growth
Sales$0$2.94M$755M
Sales growth--+256×
Profit
Gross margin-42%7.4%
Operating margin-−27×−31%
Net margin-−153×−49%
What growth costs, per sales dollar
General and admin-26×-
Pay in shares-263%1.5%
Capital spending-17×10%
Cash
Cash from operations−$87.9M−$103M$95.5M
Free cash flow−$276M−$154M$16.7M
Balance sheet
Cash and short-term investments$253M$72.6M$182M
Debt$0$602M$390M
Net cash$253M−$530M−$208M
Returns and shares
Shares (diluted)140M141M174M

What growth costs

Overheads have fallen as a share of sales as the Texas plant filled up, but one year is too little to call a trend. The real cost of growing is the cell plant: a large bill not yet financed, paid so far by selling shares and bonds that turn into shares.

The evidence under this - 3 claims
C53facthigh confidence
Selling, general and administrative cost was $235.3M against $755.3M of 2025 sales (31%), $123.5M against $427.8M in the first half of 2026 (29%) and $106.1M against $186.2M a year earlier (57%); T1 reports no research-and-development line since 2024, and stock pay was $11.4M in 2025.
historical · FY2025, H1 2025 and H1 2026written 2026-10-04
C17facthigh confidence
G2_Austin's first phase now costs $510M, from $400M-$425M in March, and first cells moved from Q4 2026 to Q1 2027; the company blames tight Texas data-centre construction. By November the steel was up, all Phase 1 tools were at US ports and MEP work had begun, but T1 matched capital spending to the timing of the unclosed financing. On the 12 November call management moved first production from March towards April 2027 and said that, assuming financial close by year-end, construction, commissioning and ramp would finish by about mid-2027.
  1. 2026-11-12editedthe Q3 release: construction progress, spending paced to the financing, no first-cell date given
  2. 2026-11-12editedthe Q3 call gives a conditional first-cell date: towards April 2027, ramped by mid-2027 if the financing closes by year-end
current state · 2026-11-12written 2026-09-29
C18facthigh confidence
In March T1 targeted G2's full financing early in Q2 2026; on the August call an analyst noted it had slipped from May to June to July. On 12 November it was still unclosed: T1 is in exclusive negotiations with institutional investors for a mainly debt financing that 'may include or require' new equity or equity-linked securities, bridged by $120M of convertible notes in July and $50M more on 30 September.
  1. 2026-11-12editedthe Q3 release: financing still unclosed, exclusive talks for a mainly debt package that may include equity
current state · 2026-11-12written 2026-09-29

The last report (12 Nov)

Quarter ended September 2026, filed figures.

-7%
Sales growth
against the same quarter a year earlier
-21.4%
Growth from the quarter before
against 40.8% the quarter before that
-28¢
Operating profit
per dollar of sales

Third-quarter sales were $196.6M, down from $250.1M, as T1 kept 326 MW of panels in stock for next year's contracts. About 97% still went to Trina.

The panels made a $16.7M gross profit, but the tax credit on them was worth roughly $51M, so without it they lost about $34M. T1 has sold none of its $155.3M of 2026 credits.

The cell plant's loan is still being negotiated and may bring new shares, and unrestricted cash fell to $59.5M. Other buyers signed for more than 3.5 GW of next year's output. On the call, management put first cells around April, but only if the loan closes by year-end.

What it did to the thesisIt answered the test on the wrong side: no credit sale, no plant loan, and a gross loss once the credit is taken out. The new buyers for next year ease the worry about depending on Trina, but only once they show up in sales.

The quarter in detail

Sales growth from the previous quarter, filed figures. The company has restated its own history, so a quarter either side of the restatement may describe a different business; n/c marks one that does not compare.

Earnings per share $-0.12 against $-0.11 expected.

The evidence under this - 6 claims
C59estimatemedium confidence
In Q3 2026 T1 made 1,056 MW of modules and added 326 MW to stock, so about 730 MW shipped; net sales were $196.6M, $189.9M to the Trina Group, and gross profit $16.7M with no tariff refund. Take out the credit at 7 cents on about 730 MW (about $51M) and the quarter was a gross loss near $34M, on revenue near 26 cents a watt.
against this
  • Shipped volume is derived from production less the inventory build; T1 does not state MW sold.
  • Management attributes the margin to facility costs of building stock, and quotes higher prices for 2027 contracts (C60).
historical · Q3 2026written 2026-11-12
C39facthigh confidence
T1 sold its 2025 credits for cash: $160M at $0.91 in December 2025 and the last $39.1M at $0.93 in June 2026. By 12 November 2026 it had sold none of the $155.3M of 2026 credits generated through Q3, reporting only that several conversations had advanced; on the call the CFO said the tax-equity market had been slow to develop this year, particularly for non-investment-grade sellers. Government grants receivable were $139.1M at 30 September.
  1. 2026-11-12editedthe Q3 release reports no 2026 credit sale, $155.3M generated and grants receivable of $139.1M
  2. 2026-11-12editedthe Q3 call: the CFO says the tax-equity market has been slow for non-investment-grade sellers
current state · 2026-11-12written 2026-09-29
C18facthigh confidence
In March T1 targeted G2's full financing early in Q2 2026; on the August call an analyst noted it had slipped from May to June to July. On 12 November it was still unclosed: T1 is in exclusive negotiations with institutional investors for a mainly debt financing that 'may include or require' new equity or equity-linked securities, bridged by $120M of convertible notes in July and $50M more on 30 September.
  1. 2026-11-12editedthe Q3 release: financing still unclosed, exclusive talks for a mainly debt package that may include equity
current state · 2026-11-12written 2026-09-29
C17facthigh confidence
G2_Austin's first phase now costs $510M, from $400M-$425M in March, and first cells moved from Q4 2026 to Q1 2027; the company blames tight Texas data-centre construction. By November the steel was up, all Phase 1 tools were at US ports and MEP work had begun, but T1 matched capital spending to the timing of the unclosed financing. On the 12 November call management moved first production from March towards April 2027 and said that, assuming financial close by year-end, construction, commissioning and ramp would finish by about mid-2027.
  1. 2026-11-12editedthe Q3 release: construction progress, spending paced to the financing, no first-cell date given
  2. 2026-11-12editedthe Q3 call gives a conditional first-cell date: towards April 2027, ramped by mid-2027 if the financing closes by year-end
current state · 2026-11-12written 2026-09-29
C60management claimmedium confidence
By 12 November 2026 T1 had more than 3.5 GW of its 2027 G1 capacity under contract after signing more than 1.58 GW of new offtakes, including Avantus, and plans to make 5.3 GW in 2027; it quotes leading-edge module prices in the mid-$0.30s a watt with imported cells and mid-$0.40s with US cells after the Section 232 proclamation. On the call the CFO said the new contracts are weighted mainly to imported cells, that T1 is holding back G2-cell contracts for 2027 until the financing and the 232 onshoring terms are known, and that some 2027 volume moved into 2028. The 10-Q adds that on 29 October T1 issued warrants for up to 500,000 shares at $0.01 a share in connection with certain commercial contracts.
against this
  • Contract volumes and prices are not filed; the 10-Q at 30 June showed 1.3 GW contracted for 2027 (C23).
  • Q3 sales were still 97% to the Trina Group (C59).
  1. 2026-11-12editedthe Q3 call: the new offtakes are mainly imported-cell modules, and G2-cell contracting for 2027 is held back; the 10-Q's warrants issued with commercial contracts
current state · 2026-11-12written 2026-11-12
C20facthigh confidence
At 30 June 2026 T1 owed $583.4M of principal: $65M to Trina, $173.4M under the HSBC plant loan, $161M of 5.25% notes converting at $6.93 and $184M of 4.00% notes at $6.80; $170M of 4.75% notes converting at $4.46 followed. At 30 September debt was carried at $703.4M ($495.1M of convertible notes) and cash at $137.0M, $59.5M unrestricted.
  1. 2026-11-12editedcash and debt carrying values at 30 September from the Q3 release
current state · 2026-09-30written 2026-09-29
What management did with the money

Management paid $135M for the cell patents it had licensed, part in shares. But Trina kept a free licence to the same patents. The cell plant has been funded with convertible bonds, loans that turn into shares, while the promised main financing is still unsigned.

Insiders in 2026Q2: 7 purchases and 13 sales, from their Form 4 filings.

The evidence under this - 4 claims
C14facthigh confidence
On 28 July 2026 T1 bought the TOPCon patents from Evervolt for $135M: $2M cash, $60M paid in stock on 31 July, and $25M, $30M and $18M due on 30 September, 15 and 30 October in cash or stock at a 15% discount.
historical · July 2026written 2026-09-29
C45factmedium confidence
T1 bought the patents subject to licences already granted: when Trina sold them to Evervolt it kept a royalty-free, perpetual, worldwide, sub-licensable licence, so Trina can still use and license the technology T1 paid $135M for.
against this
  • Schedule E, which lists the assumed licences, was not read; the recital and the definition of Existing Third-Party Licenses are.
  • Management values the deal on the licence fees it saves to 2029, which Trina's licence does not change (C14).
current state · 2026-07-28written 2026-09-29
C18facthigh confidence
In March T1 targeted G2's full financing early in Q2 2026; on the August call an analyst noted it had slipped from May to June to July. On 12 November it was still unclosed: T1 is in exclusive negotiations with institutional investors for a mainly debt financing that 'may include or require' new equity or equity-linked securities, bridged by $120M of convertible notes in July and $50M more on 30 September.
  1. 2026-11-12editedthe Q3 release: financing still unclosed, exclusive talks for a mainly debt package that may include equity
current state · 2026-11-12written 2026-09-29
C20facthigh confidence
At 30 June 2026 T1 owed $583.4M of principal: $65M to Trina, $173.4M under the HSBC plant loan, $161M of 5.25% notes converting at $6.93 and $184M of 4.00% notes at $6.80; $170M of 4.75% notes converting at $4.46 followed. At 30 September debt was carried at $703.4M ($495.1M of convertible notes) and cash at $137.0M, $59.5M unrestricted.
  1. 2026-11-12editedcash and debt carrying values at 30 September from the Q3 release
current state · 2026-09-30written 2026-09-29
05

The price, and where we disagree

In short. Fair. Cheap if everything goes right, but the promised profit is mostly a government tax credit, and that credit is the thing in doubt.

Share price
$2.28
close,
Price for each $1 of net worth
2.4
rivals' middle 0.2

The shares are 83% below June's high and barely moved over the past two weeks, and about a third of the freely traded shares are sold short. Earlier falls came from buyers paying less per dollar of sales, not from sales shrinking.

Three things matter next. The import floor starts on 4 December. The cell plant's loan is in exclusive talks and could close at any time, or bring new shares. And Treasury still owes the rules on who counts as too close to China, which decide whether anyone will buy T1's credits.

The evidence under this - 6 claims
C35facthigh confidence
The shares closed at $2.13 on 11 November 2026, 83% below the $12.49 high of 4 June and 40.3% below the $3.57 of 28 September; 73.5M shares were sold short at the 15 October settlement, down from 77.1M at 30 September, 4.2 days of trading.
  1. 2026-10-27editedre-struck at the 26 October close of $2.12 after a 40.6% fall since the pack
  2. 2026-11-12editedre-struck at the 11 November close of $2.13
current state · 2026-11-11written 2026-09-29
C36facthigh confidence
Over the six months to 28 September the price fell 38.0% while revenue per share rose 126.4%: the whole fall was a lower price per dollar of sales. The further 40.6% fall to 26 October followed no new filing or sales figure.
  1. 2026-10-27editedthe six-month decomposition is dated to the pack; the later fall is stated in C35
historical · 2026-03-27 to 2026-09-28written 2026-09-29
C25facthigh confidence
From 4 December 2026 an imported solar cell may not enter below $0.22 a watt and a module below $0.38, plus a 15% duty; Commerce may grant tariff offsets to companies building US cell or wafer plants, and rescind them.
current state · 2026-08-11written 2026-09-29
C18facthigh confidence
In March T1 targeted G2's full financing early in Q2 2026; on the August call an analyst noted it had slipped from May to June to July. On 12 November it was still unclosed: T1 is in exclusive negotiations with institutional investors for a mainly debt financing that 'may include or require' new equity or equity-linked securities, bridged by $120M of convertible notes in July and $50M more on 30 September.
  1. 2026-11-12editedthe Q3 release: financing still unclosed, exclusive talks for a mainly debt package that may include equity
current state · 2026-11-12written 2026-09-29
C11facthigh confidence
Treasury's February 2026 notice on the foreign-entity rules covered material assistance only; it said the definition of a prohibited foreign entity is still to be proposed, and left ownership and effective-control questions to later guidance.
current state · 2026-09-29written 2026-09-29
C39facthigh confidence
T1 sold its 2025 credits for cash: $160M at $0.91 in December 2025 and the last $39.1M at $0.93 in June 2026. By 12 November 2026 it had sold none of the $155.3M of 2026 credits generated through Q3, reporting only that several conversations had advanced; on the call the CFO said the tax-equity market had been slow to develop this year, particularly for non-investment-grade sellers. Government grants receivable were $139.1M at 30 September.
  1. 2026-11-12editedthe Q3 release reports no 2026 credit sale, $155.3M generated and grants receivable of $139.1M
  2. 2026-11-12editedthe Q3 call: the CFO says the tax-equity market has been slow for non-investment-grade sellers
current state · 2026-11-12written 2026-09-29
The betPriced for success
If it works
1.3×
from today's value, valued like the cheaper of its two rivals
If it fails
keep 0%
of today's market value: what the worst case leaves shareholders
How we value it

No fair value: the analysts' forecasts show no lasting operating profit after stock pay, so a value built on earnings would rest on a guess; the bet prices it instead.

How we read the multiple

The whole company, debt included, is valued at about $1.3B. Management says that once the factories run fully it will earn $375M to $450M a year before interest, tax and depreciation, and repeated that in November. Against that, the price looks cheap.

But at that size the tax credit alone is about $434M a year, more than the middle of that range. So the price is paying for the credit, which shrinks from 2030, ends after 2032, and which the ties to Trina could cost.

Against its own history. The company has no long record of profit to compare with, so there is no normal to measure today's price against.

The evidence under this - 4 claims
C37estimatemedium confidence
At $2.13 T1's enterprise value is about $1.3B: $0.64B of shares, $703M of debt and $75M of preferred at their 30 September carrying values, less $137M of cash; that is about 2.8 to 3.4 times the guided run-rate EBITDA.
against this
  • Q4 cash spending and any equity in the G2 financing would lower the cash or raise the share count.
  • Restricted cash of $77.5M is not freely available.
  1. 2026-10-27editedre-struck at the 26 October close of $2.12
  2. 2026-11-12editedre-struck at the 11 November close on the 30 September balance sheet
current state · 2026-11-11written 2026-09-29
C09management claimlow confidence
Management guides to adjusted EBITDA at an annual run-rate of $375M to $450M once 5 GW of G1 modules run with 2.1 GW of G2 cells, and $650M to $700M with 5 GW of each; the Q3 deck of 12 November reaffirmed both unchanged.
against this
  • The same release that set it (March 2026) put first cells in Q4 2026 and G2 financial close early in Q2; both slipped (C17, C18).
  • Q2 2026 adjusted EBITDA excluding the tariff refund was about -$13.7M (C05).
  • Q3 2026 adjusted EBITDA was -$16.4M, and G2 spending is now paced to a financing not yet closed (C17, C18).
  1. 2026-11-12editedreaffirmed unchanged in the Q3 deck
forwardwritten 2026-09-29
C10estimatemedium confidence
At the guided scale the Section 45X credit alone is about $434M a year, 5 GW of modules at 7 cents plus 2.1 GW of cells at 4 cents: more than the $412M midpoint of the adjusted EBITDA guide.
derived5,000 MW x $0.07 = $350M plus 2,100 MW x $0.04 = $84M (C06, C07) against the $375M-$450M guide (C09).
against this
  • The guide may assume higher module prices after the 4 December floor, so profit before credits need not be negative (C25).
  • Not every watt made is sold to a third party within the year, which is when the credit is earned.
forwardwritten 2026-09-29
C44inferencemedium confidence
Section 45X ends after 2032, so the credit that carries T1's guided profit is worth 75%, 50% and 25% in 2030 to 2032; after that T1 must earn its margin against imports at the Section 232 floor.
derivedC06, C10, C25
against this

The 232 floor has no end date and may lift domestic module prices by more than the credit is worth (C25).

forwardwritten 2026-09-29
Priced against its rivals

The competitors its own annual report names, each confirmed against the rival's filing. Measured on price for each $1 of net worth, cheapest first:

TickerCompanyprice for each $1 of net worth
JKSJinkoSolar Holding0.1×
CSIQCanadian Solar0.2×
FSLRFirst Solar1.8×
TET1 Energy2.4×

The middle of the other 3 is 0.2. T1 Energy Inc is dearest of 4.

Rivals' figures come from a data provider, so read the spread of the group rather than any single pair.

Its rivals are profitable and T1 is not, so the comparison says more about the credit it lacks than about the price.

The bet: what it pays if it works

Think of this as a bet that a Texas solar factory keeps earning a tax credit. Even if T1 sells about three gigawatts of panels a year and the credit holds, the company would be worth roughly what it is today, because the price already pays for that plan.

If it fails, little is left for shareholders: debt and preferred stock are paid first, and without the credit its panels have kept selling at a loss.

EBITDA in two to three yearsGigawatts of modules sold a year neededValued like its peersLike the cheapest
$247.50M (the big win)about 3 at 100% kept6.6×1.3×
$412.50Mabout 5 at 100% kept11.0×2.2×
$412.50M (market forecast)about 5 at 100% kept11.0×2.2×

SEIA and Wood Mackenzie see US installs flat near 44 GWdc a year to 2031; 5 GW, an 11% share, fills G1_Dallas and earns about $412.5M, the plant's ceiling rather than the market's. On that forecast, $412.50M pays 2.2× from today's value: a Fair bet on the market case.

To pay 2× (a Fair bet) it would need about $376.80M of EBITDA (about 5 gigawatts of modules sold a year); to pay 5× (a Cheap bet), about $941.99M of EBITDA (about 11 gigawatts of modules sold a year), at the same multiple.

The steps it has to take

  • Done G1_Dallas assembling modules at scale
  • Done First third-party offtakes for modules using G2_Austin cells
  • Slipped 2026 Section 45X credits sold to an unrelated buyer due 2027-03
  • Slipped G2_Austin's comprehensive financing closes due 2027-03
  • Slipped G2_Austin ships its first saleable cells into G1 modules due 2027-04
  • Not started Treasury proposes the foreign-entity rules and T1 says it stays eligible due 2027-06
  • Not started Trina Group below half of net sales in a quarter due 2027-12
  • Not started 5 GW of G1 modules running with 2.1 GW of G2 cells due 2027-12
The detail behind the label
Rating
Expensive
the big win's payoff against the 2× and 5× lines
At their midpoint
6.6×
the same success, valued between the two
Cheap bet
not on price
the big win pays five times only below the company's debt
Market case
2.2×
a fair bet if the market forecast holds
The evidence under this - 6 claims
C05facthigh confidence
In Q2 2026 T1 made 935 MW of modules and reported net sales of $250.1M, gross profit of $49.1M including $24.4M of refunded tariffs, an operating loss of $22.8M and adjusted EBITDA of $10.7M including the refund.
historical · Q2 2026written 2026-09-29
C09management claimlow confidence
Management guides to adjusted EBITDA at an annual run-rate of $375M to $450M once 5 GW of G1 modules run with 2.1 GW of G2 cells, and $650M to $700M with 5 GW of each; the Q3 deck of 12 November reaffirmed both unchanged.
against this
  • The same release that set it (March 2026) put first cells in Q4 2026 and G2 financial close early in Q2; both slipped (C17, C18).
  • Q2 2026 adjusted EBITDA excluding the tariff refund was about -$13.7M (C05).
  • Q3 2026 adjusted EBITDA was -$16.4M, and G2 spending is now paced to a financing not yet closed (C17, C18).
  1. 2026-11-12editedreaffirmed unchanged in the Q3 deck
forwardwritten 2026-09-29
C12management claimlow confidence
T1 says the February guidance validates its compliance plan and that it expects to be eligible for 45X; it bought cells for part of 2026 output from suppliers certifying non-PFE status, and in November 2026 said third-party diligence put about 65% of its cell supply-chain material through Q2 outside foreign entities of concern, above the 50% safe-harbour ratio.
against this
  • The notice it cites left ownership and effective control, which its restructuring addressed, to future guidance (C11).
  • A short seller alleges $65M of Trina cell purchases in Q1 2026 (C15); the 10-Q shows $428.1M bought from the Trina Group in the half without naming the goods (C03).
  • The SEC opened an investigation in September 2026 into T1's public disclosures on its 45X eligibility (C62).
  1. 2026-11-12editedthe Q3 release adds management's figure of about 65% non-foreign-entity material through Q2
  2. 2026-11-13editedthe SEC's investigation into T1's 45X-eligibility disclosures (C62) is new counter-evidence to management's eligibility claim
current state · 2026-11-12written 2026-09-29
C20facthigh confidence
At 30 June 2026 T1 owed $583.4M of principal: $65M to Trina, $173.4M under the HSBC plant loan, $161M of 5.25% notes converting at $6.93 and $184M of 4.00% notes at $6.80; $170M of 4.75% notes converting at $4.46 followed. At 30 September debt was carried at $703.4M ($495.1M of convertible notes) and cash at $137.0M, $59.5M unrestricted.
  1. 2026-11-12editedcash and debt carrying values at 30 September from the Q3 release
current state · 2026-09-30written 2026-09-29
C59estimatemedium confidence
In Q3 2026 T1 made 1,056 MW of modules and added 326 MW to stock, so about 730 MW shipped; net sales were $196.6M, $189.9M to the Trina Group, and gross profit $16.7M with no tariff refund. Take out the credit at 7 cents on about 730 MW (about $51M) and the quarter was a gross loss near $34M, on revenue near 26 cents a watt.
against this
  • Shipped volume is derived from production less the inventory build; T1 does not state MW sold.
  • Management attributes the margin to facility costs of building stock, and quotes higher prices for 2027 contracts (C60).
historical · Q3 2026written 2026-11-12
C19management claimmedium confidence
The CFO said in August that $200M to $250M of Phase 1 capex remained after the July notes, and that the planned financing may cover more than G2 and may 'prime existing debt structures'; the Q3 deck says $250M of the $510M had been spent, leaving about $260M.
against this
  • The estimate has risen twice in five months (C17).
  • Priming would rank new lenders ahead of the $515M of existing convertible notes (C20).
  1. 2026-11-12editedthe Q3 deck puts $250M of the $510M already spent
forwardwritten 2026-09-29

Where we disagree with the market

The market believes

An American solar champion that new trade rules and the tax credit favour.

We believe

Its profit is a tax credit it cannot yet prove it keeps, while Trina is its customer and supplier.

Most analysts rate it a buy, and one broker called the short seller's case against it false. They read adjusted profit with the credit inside it.

The filings show Trina on both sides of the business, as its only customer and its biggest supplier, and nobody outside has yet bought T1's 2026 credits. We would be wrong if an outside buyer buys them and the cell plant is financed with loans rather than shares.

What analysts say, and the evidence
Analysts positive
67%
of 9, 1 Sep
Four months earlier
100%
of 5, 1 May
The evidence under this - 6 claims
C38factmedium confidence
Analysts are split 3 buy, 3 hold, 1 sell; the positive share fell from 100% of 5 analysts in May to 66.7% of 9 by September.
current state · 2026-09-01written 2026-09-29
C15factmedium confidence
A short seller, Fuzzy Panda, published in May and June 2026 that T1 bought at least $65M of Trina cells in Q1 2026 and that Evervolt's owner has long Trina ties; Roth called every part misleading or false.
against this
  • Roth: Evervolt is a Singapore conglomerate that bought the IP at auction, and T1 did extensive diligence (S21).
  • The short seller profits if the price falls; its invoices are not public.
historical · May-June 2026written 2026-09-29
C10estimatemedium confidence
At the guided scale the Section 45X credit alone is about $434M a year, 5 GW of modules at 7 cents plus 2.1 GW of cells at 4 cents: more than the $412M midpoint of the adjusted EBITDA guide.
derived5,000 MW x $0.07 = $350M plus 2,100 MW x $0.04 = $84M (C06, C07) against the $375M-$450M guide (C09).
against this
  • The guide may assume higher module prices after the 4 December floor, so profit before credits need not be negative (C25).
  • Not every watt made is sold to a third party within the year, which is when the credit is earned.
forwardwritten 2026-09-29
C02facthigh confidence
One customer took about 100% of T1's net sales in the first half of 2026 and all trade receivables; the 10-Q reports $450.2M of gross module sales to the Trina Group in that half, presented as related-party sales.
historical · H1 2026written 2026-09-29
C03facthigh confidence
T1 bought $428.1M of materials and components from the Trina Group under supply agreements in the first half of 2026, against $87.0M a year earlier; total cost of sales in that half was $349.6M.
historical · H1 2026written 2026-09-29
C39facthigh confidence
T1 sold its 2025 credits for cash: $160M at $0.91 in December 2025 and the last $39.1M at $0.93 in June 2026. By 12 November 2026 it had sold none of the $155.3M of 2026 credits generated through Q3, reporting only that several conversations had advanced; on the call the CFO said the tax-equity market had been slow to develop this year, particularly for non-investment-grade sellers. Government grants receivable were $139.1M at 30 September.
  1. 2026-11-12editedthe Q3 release reports no 2026 credit sale, $155.3M generated and grants receivable of $139.1M
  2. 2026-11-12editedthe Q3 call: the CFO says the tax-equity market has been slow for non-investment-grade sellers
current state · 2026-11-12written 2026-09-29
06

What could go wrong, and how we would know

The risks

  • The credit could be denied. If Treasury's rules treat T1 as too close to Trina, the credit that is its whole profit disappears.
  • More shares to come. The cell plant still needs about $260M, its loan may come with new shares, and bonds convert into shares at $4.46.
  • The credit runs out. It shrinks from 2030 and ends after 2032, when T1 must earn its margin on price alone.
  • A patent fight. First Solar is suing T1 over the cells it imports, and Trina keeps a free licence to T1's patents.
  • Investigators are looking. Since September the SEC has been investigating what T1 told investors about qualifying for the tax credit, and prosecutors are looking at a director's 2023 share sales.
The evidence under this - 9 claims
C11facthigh confidence
Treasury's February 2026 notice on the foreign-entity rules covered material assistance only; it said the definition of a prohibited foreign entity is still to be proposed, and left ownership and effective-control questions to later guidance.
current state · 2026-09-29written 2026-09-29
C12management claimlow confidence
T1 says the February guidance validates its compliance plan and that it expects to be eligible for 45X; it bought cells for part of 2026 output from suppliers certifying non-PFE status, and in November 2026 said third-party diligence put about 65% of its cell supply-chain material through Q2 outside foreign entities of concern, above the 50% safe-harbour ratio.
against this
  • The notice it cites left ownership and effective control, which its restructuring addressed, to future guidance (C11).
  • A short seller alleges $65M of Trina cell purchases in Q1 2026 (C15); the 10-Q shows $428.1M bought from the Trina Group in the half without naming the goods (C03).
  • The SEC opened an investigation in September 2026 into T1's public disclosures on its 45X eligibility (C62).
  1. 2026-11-12editedthe Q3 release adds management's figure of about 65% non-foreign-entity material through Q2
  2. 2026-11-13editedthe SEC's investigation into T1's 45X-eligibility disclosures (C62) is new counter-evidence to management's eligibility claim
current state · 2026-11-12written 2026-09-29
C18facthigh confidence
In March T1 targeted G2's full financing early in Q2 2026; on the August call an analyst noted it had slipped from May to June to July. On 12 November it was still unclosed: T1 is in exclusive negotiations with institutional investors for a mainly debt financing that 'may include or require' new equity or equity-linked securities, bridged by $120M of convertible notes in July and $50M more on 30 September.
  1. 2026-11-12editedthe Q3 release: financing still unclosed, exclusive talks for a mainly debt package that may include equity
current state · 2026-11-12written 2026-09-29
C21facthigh confidence
T1 had 299.5M shares at 30 September 2026 against 155.9M weighted in Q2 2025 (294.5M on 10 August); up to 32.3M more are registered for the July notes, and $66M of preferred converts at $1.70 to $1.90, with Trina holding a matching right at $1.70 to December 2027.
  1. 2026-11-12edited299.5M shares at 30 September in the Q3 balance sheet
current state · 2026-09-30written 2026-09-29
C31facthigh confidence
First Solar sued T1 for infringing a TOPCon cell patent; the trade-commission complaint it joined is being withdrawn, and the district-court suit continues.
current state · 2026-09-15written 2026-09-29
C32facthigh confidence
In November 2025 the DOJ subpoenaed T1 and a current executive and director over his 2023 share sales, and the SEC asked for similar documents; the Q3 2026 10-Q repeats both and says T1 is cooperating with the DOJ and the SEC.
  1. 2026-11-13editedthe Q3 10-Q repeats the DOJ subpoenas and the SEC document request; refresh_by rolled to the FY2026 10-K
current state · 2026-11-12written 2026-09-29
C44inferencemedium confidence
Section 45X ends after 2032, so the credit that carries T1's guided profit is worth 75%, 50% and 25% in 2030 to 2032; after that T1 must earn its margin against imports at the Section 232 floor.
derivedC06, C10, C25
against this

The 232 floor has no end date and may lift domestic module prices by more than the credit is worth (C25).

forwardwritten 2026-09-29
C45factmedium confidence
T1 bought the patents subject to licences already granted: when Trina sold them to Evervolt it kept a royalty-free, perpetual, worldwide, sub-licensable licence, so Trina can still use and license the technology T1 paid $135M for.
against this
  • Schedule E, which lists the assumed licences, was not read; the recital and the definition of Existing Third-Party Licenses are.
  • Management values the deal on the licence fees it saves to 2029, which Trina's licence does not change (C14).
current state · 2026-07-28written 2026-09-29
C62facthigh confidence
In September 2026 the SEC's Fort Worth Regional Office told T1 it is investigating T1's public disclosures about its eligibility for 45X tax credits and certain other accounting matters; T1 says it will cooperate fully and cannot predict the duration or outcome. The 10-Q filed 12 November 2026 is the first place it was disclosed; no 8-K reported it.
current state · 2026-11-12written 2026-11-13
What we still do not know
  • What the $428.1M bought from Trina in the first half was, and how many of those were cells.
  • What Treaty Oak and Clearway agreed to pay, and when the panels are due.
  • Whether Evervolt, the Singapore firm paid $135M for the patents, has ties to Trina, as a short seller claims.
The evidence under this - 3 claims
C03facthigh confidence
T1 bought $428.1M of materials and components from the Trina Group under supply agreements in the first half of 2026, against $87.0M a year earlier; total cost of sales in that half was $349.6M.
historical · H1 2026written 2026-09-29
C24factmedium confidence
Treaty Oak signed in December 2025 for at least 900 MW over three years, and Clearway in August 2026 for 641 MW, both of modules using G2_Austin cells; neither price nor delivery schedule is disclosed.
current state · 2026-08-12written 2026-09-29
C15factmedium confidence
A short seller, Fuzzy Panda, published in May and June 2026 that T1 bought at least $65M of Trina cells in Q1 2026 and that Evervolt's owner has long Trina ties; Roth called every part misleading or false.
against this
  • Roth: Evervolt is a Singapore conglomerate that bought the IP at auction, and T1 did extensive diligence (S21).
  • The short seller profits if the price falls; its invoices are not public.
historical · May-June 2026written 2026-09-29

What would change our view

  1. Unattractive→NeutralThe credit is proven and the plant financed

    It needs all of:

    • ○T1 sells its 2026 tax credits to an outside buyer.watched as it happens
    • ○The main financing for the cell plant is signed.watched as it happens
  2. Unattractive→AttractiveThe cells arrive and the customers diversify

    It needs all of:

    • ○The cell plant ships its first cells into T1's panels.watched as it happens
    • ○Trina's share of sales falls below half.checked at the next results, due by 31 Mar
    • ○Treasury writes the foreign-ownership rules and T1 says it still qualifies.checked at the next results, due by 31 Mar

What is coming

  • 23 November 2026 Q3 2026 Form 10-Q: The notes the release omits: Trina purchases by type, contracted volumes and prices, the debt schedule and any subsequent-event financing.
Every dated event ahead
  • 23 November 2026 Q3 2026 Form 10-Q: The notes the release omits: Trina purchases by type, contracted volumes and prices, the debt schedule and any subsequent-event financing.
  • 4 December 2026 Section 232 import price floor on solar cells and modules takes effect: Whether a floor lifts US module prices for T1, or mostly raises the cost of the imported cells it still buys.
  • 31 March 2027 Q4 2026 results: Whether 2026 credits sold, the G2 financing closed mainly on debt, and a first-cell date stands.
  • April 2027 First cells from G2_Austin: Whether the cell plant starts towards April 2027, the date the Q3 call gave if financing closes by year-end; another slip strains the financing and the guide.
Since we wrote this
Written
29 Sep
Price the thesis read
$3.57
28 Sep
Latest close
$2.28
close, · -36.1% since
  • 13 NovNewsSEC investigating T1's tax-credit disclosures; view held UnattractiveThe 10-Q says the SEC opened an investigation in September into what T1 told investors about qualifying for the 45X credit. Nothing is found yet; it weighs on the case's central question.
  • 12 NovEarningsQ3: no credit sale, no plant financing; view heldThe tax credits are still unsold and the cell plant's financing still in talks, with spending slowed to wait for it. New 2027 contracts above 3.5 GW are the one gain.
  • 12 NovEarningsCall read: first cells around April, if the loan closes; view heldManagement dated first cells towards April 2027, but only if the plant's loan closes by year-end. No tax credit is sold and the credit market is slow for T1.
  • 30 OctNewsT1 adds 1.58 GW of 2027-28 module contracts with Avantus; terms unread. View heldT1 signs offtake contracts for more than 1.58 GW of modules with Avantus subsidiaries.
  • 27 OctPrice moveShares fell 41% in four weeks with no filing; view heldPrice claims were re-struck at $2.12. The view rests on the credit and the G2 financing, which the 13 November report tests.
  • 22 OctNewsPatent payments keep being made in shares; waiver terms unreadThe October payment is in stock at about $3.01. A Commerce waiver was announced but its terms could not be read, so nothing moved.
  • 5 OctThesis reviewThe bet now names what it ridesThe owner asked that every bet name the macro trend behind it, after BWXT's bet was missing its chief executive's case for nuclear over gas.
  • 4 OctThesis reviewOwner's checklist: revenue streams, cost of growth, management, catalystsThe owner's checklist found the method silent on who runs the company, what growth costs, where the money comes from and what is dated ahead; this pass fills those four blocks from the proxy and filings.
  • 29 SepThesis writtenUnattractive, medium convictionThe promised profit is a tax credit whose eligibility is unproven while Trina is both only customer and main supplier, and the cell plant is late, over budget and diluting shareholders.

Also checked 2 times with nothing new to act on.

Sources 41

Where this came from

Sources - 41

Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.

  1. S01primarycompany filing2026-03-31
    Item 1 business: G1_Dallas and G2_Austin, the Trina Business Combination, the FEOC Restructuring, the IP licence moving to Evervolt, the Module Operational Support and Sales Agency agreements with Trina Solar (U.S.) and their commission terms, the four named competitors, 562 employees
    backsC01C04C12C13C45C30C52C53C57
  2. S02primarycompany filing2026-08-12
    one customer at about 100% of H1 2026 sales; sales to and purchases from the Trina Group; deferred revenue from Trina offtakes; 5.4 GW contracted; debt note and conversion prices; preferred stock and Trina anti-dilution right; tariff refunds; DOJ and SEC document requests; RWE suit; First Solar patent suits and the ITC hearing date; material weakness; 45X at about 7 cents a watt; G2 capex of $510M; 294,527,066 shares at 10 August 2026
    backsC01C02C03C05C07C12C13C14C17C20C21C23C31C32C33C34C36C39C52C53C57
  3. S03primarycompany filing2026-08-12
    the statements, adjusted EBITDA reconciliation with the $24.4M tariff refund, 935 MW produced, cash of $156.4M, the 2025 45X credit sale at $0.93, early-stage talks on 2026 credits, Clearway 641 MW, Evervolt IP, G2 first cells in Q1 2027
    backsC03C05C20C22C24C36C39
  4. S04primarycompany filing2026-08-12
    3 GW of firm cost-plus and fixed-margin contracts for 2026, unchanged run-rate adjusted EBITDA guidance of $375M-$450M and $650M-$700M, the Evervolt payment schedule, the Hemlock and Corning supply claims
    backsC09C14C23
  5. S05primarytranscript2026-08-12
    Q2 2026 earnings call transcript (FMP)
    data/cache/transcripts/TE-2026Q2.json
    the analyst questions (Roth, BTIG, Johnson Rice, Bernstein, Needham) on financing timing, Clearway terms, remaining capex, cost pass-through and SG&A; management's answers that remaining Phase 1 capex is $200M-$250M and the financing may 'prime existing debt structures'. The questions are a separate origin from the answers
    As it relates to the financing, you guys had talked about end of May and then it was end of June and then end of July. So we're sitting here still kind of mid-August.
    backsC09C18C19C24
  6. S06primarycompany filing2026-07-28
    about 835 MW of Q2 module sales; adjusted EBITDA of -$14.5M to -$11.5M excluding the tariff refund; G2 capex raised from $425M to $510M; first cells moved from before year-end 2026 to Q1 2027
    backsC05C17
  7. S07primarycompany filing2026-07-28
    $135M total, $2M cash, $60M first tranche in stock, $25M/$30M/$18M due 30 Sep, 15 Oct and 30 Oct in cash or stock at a 15% discount to a five-day VWAP
    backsC14
  8. S08primarycompany filing2026-07-30
    $120M principal, conversion price about $4.46, 20% premium to $3.72, described as a bridge to the comprehensive financing
    backsC18C20C57
  9. S09primarycompany filing2026-09-29
    a further $50.0M of the same notes sold to one existing shareholder, closing 30 September 2026, for G2 Phase 1 and general purposes
    backsC18C20C57
  10. S10primarycompany filing2026-03-31
    2.79 GW produced in 2025; G2 remaining capex of about $350M; full financial close targeted early in Q2 2026; first cells in Q4 2026; $160M 45X sale at $0.91; Treaty Oak 900 MW three-year contract; 3 GW contracted for 2026; run-rate EBITDA guidance
    backsC09C17C18C24C39C40C41
  11. S11primarycompany filing2026-08-28
    the maximum shares issuable on the July notes including make-whole shares
    backsC21
  12. S12primarygovernment data2025-07-04
    4 cents a watt for cells and 7 cents for modules; 75% in 2030, 50% in 2031, 25% in 2032, nil after; no credit for a specified foreign entity or foreign-influenced entity, or a component with material assistance from a prohibited foreign entity
    7 cents, multiplied by the capacity of such module (expressed on a per direct current watt basis)
    backsC06
  13. S13primarygovernment data2026-08-11
    the minimum import prices, the 15% ad valorem duty from 4 December 2026, and the onshoring program whose tariff offsets the Secretary may rescind
    (iii) $0.22 per watt for solar cells; and (iv) $0.38 per watt for solar modules.
    backsC25
  14. S14primarygovernment data2026-02-20
    the size of the US utility-scale solar build, measured by the government; Texas 40% of it
    Developers plan to add 43.4 GW of new utility-scale solar capacity in 2026
    backsC27
  15. S15secondaryindustry data2026-09-14
    Q2 2026 US utility-scale installations and module capacity near 66 GWdc
    The utility-scale segment installed 9.6 GWdc, increasing 61% year-over-year and 56% quarter-over-quarter.
    backsC26C28C46
  16. S16secondaryindustry data2026-06-30
    US module capacity more than twenty times US cell capacity
    there is currently 69.9 gigawatts (GW) of domestic module manufacturing capacity online ... the United States currently has just 3 gigawatts of solar cell manufacturing capacity
    backsC26
  17. S17primarycompany release2026-06-17
    a named rival's own account of American cells already in production
    by Q3 2026, Cartersville will make 3.3 GW each of ingots, wafers, cells, and 3.5 GW of modules a year.
    backsC29
  18. S18primaryregulator2026-02-12
    that the February notice is interim and that the definition of a prohibited foreign entity is still to be proposed
    Notice 2026-15 PDF provides that Treasury and IRS intend to propose regulations with respect to the definition of a PFE and the calculation of the material assistance cost ratio
    backsC11
  19. S19secondaryanalyst2026-02
    a law firm's reading that ownership and effective control, the questions T1's restructuring answered, were left open
    The Notice largely leaves PFE/Foreign Entity of Concern (FEOC) ownership and broader effective control questions to be addressed in future guidance.
    backsC11
  20. S20secondaryanalyst2026-06-10
    an interested party's allegation of Trina cell purchases in Q1 2026, and its claim that Evervolt's owner has long ties to Trina
    T1 Energy made at least 26 purchases of solar cells from Trina between January 2026 and March 31, 2026, spending at least $65 million.
    backsC15
  21. S21secondarynews2026-05-22
    the broker rebuttal: Evervolt a Singapore conglomerate that bought the IP at auction, credit accounting standard practice
    It is difficult to write a report with '10 Parts' and have every part be misleading and/or false.
    backsC15
  22. S22secondaryvendor data2026-09-29
    Research pack, frozen beside this thesis
    content/TE/research-pack.json
    price and range, the move decomposition, FINRA short interest settled 15 September 2026, the analyst split and its drift, the insider window, the cohort
    backsC16C35C36C38C41
  23. S23primarycompany filing2026-05-26
    22,500,000 shares sold at $8.13 to $9.20, none under a Rule 10b5-1 plan
    backsC16C55
  24. S24primarycompany release2026-09-15
    the ITC complaint T1 was a respondent to is being withdrawn; the district-court suit against T1 continues
    its intent to voluntarily withdraw its Section 337 complaint and move to terminate the investigation currently pending before the US International Trade Commission (USITC) without prejudice to refiling at a later date. The Company will continue pursuing its existing TOPCon patent lawsuits in US District Court
    backsC31
  25. S25primarycompany filing2026-07-28
    the recital that Evervolt granted Trina a royalty-free, fully paid-up, irrevocable, perpetual, worldwide and sub-licensable licence under the acquired IP; T1's assumption of existing third-party licences granted by Evervolt or Trina; the Trina patent suits against Runergy and Canadian Solar that come with the IP
    backsC45
  26. S26primarycompany filing2026-08-07
    13,615,979 shares issued to Evervolt as the $60M first tranche, registered for resale
    backsC14
  27. S27secondaryindustry data2026-09-14
    the industry body and its analyst's five-year outlook: US additions flat near 44 GWdc a year to 2031, a 216-240 GWdc safe-harbored pipeline through 2030, the December 2027 placed-in-service cliff and FEOC thresholds stepping up in 2027; read through ir_fetch. Same report and independence group as S15
    The safe-harbored pipeline, which will keep tax-credit eligibility, totals up to 240 GWdc, supporting installations through 2030, even after attrition. ... Permitting and interconnection bottlenecks constrain growth to around 44 GW annually, despite rising demand.
    backsC46
  28. S28secondarynews2026-09-21
    SEIA's September 2026 manufacturing count of US module and cell capacity, operating and under construction, as reported by the trade press; read through ir_fetch
    Operational U.S. module manufacturing capacity has reached 75.3 GW, with an additional 14.4 GW currently under construction. Domestic solar cell manufacturing infrastructure is also taking shape, with 10.6 GW of operational capacity and 19.1 GW actively being built.
    backsC47
  29. S29primaryindustry data2025-09-09
    the analyst's own post-OBBBA base and low cases for 2025-2030, and the 48E/45Y deadlines; read through ir_fetch. Co-author of the SEIA report, so not independent of S27
    From 2025-2030, our base case outlook puts total solar deployments at 246 GW dc - 4%, or 11 GW dc , lower than our pre-OBBBA outlook. ... Overall, our low case is 18% lower (44 GW dc ) than our base case over the next five years.
    backsC48
  30. S30primarycompany filing2026-07-30
    the largest US module maker's 2026 volume and adjusted EBITDA guidance with the 45X credits it assumes, its US-made third-quarter volume and its 45.1 GW contracted backlog through 2030
    backsC49C50
  31. S31secondaryvendor data2026-10-01
    peers' trailing EV/EBITDA and company value over consensus EBITDA for 2027 and 2029, and T1's own consensus EBITDA by year
    backsC50
  32. S32primarycompany filing2026-05-18
    beneficial ownership at the 8 May 2026 record date (directors and officers 22.44%, Encompass 19.99%, Trina 17.97%, BlackRock 5.3%); executive officers and tenures; the 2025 annual incentive plan design; the summary compensation table and the January 2025 transaction-bonus RSUs
    backsC54C55C56
  33. S33primarycompany filing2026-10-21
    how the third $30M Evervolt payment is being met, in shares, and how many are deferred under the 4.99% ownership cap
    backsC58
  34. S34secondaryvendor data2026-10-27
    the 26 October close and the nine-session fall from 3.39 on 9 October
    read, but no claim rests on it
  35. S35primaryregulator2026-10-15
    73,479,625 shares short at the 15 October settlement against 77,141,996 at 30 September, 4.21 days of average volume
    backsC35
  36. S36primarycompany filing2026-11-12
    Q3 2026 statements, cash, shares, credit generated, financing status, new offtakes, the 232 waiver and the 2026 and 2027 production plans
    backsC12C17C18C20C21C37C39C59C60C61
  37. S37primarycompany filing2026-11-12
    G2 spend to date ($250M of $510M), the reaffirmed run-rate guides, module price quotes after the 232 proclamation and the G2 schedule
    backsC09C17C18C19C59C60C61
  38. S38secondaryvendor data2026-11-12
    the 11 November close of $2.13
    backsC35C37
  39. S39primarytranscript2026-11-12
    Q3 2026 earnings call transcript (FMP)
    data/cache/transcripts/TE-2026Q3.json
    the G2 schedule conditional on financial close by year-end (first production moved from March towards April, ramp by mid-2027); the tax-equity market slow for non-investment-grade sellers; the new offtakes weighted to imported cells, with G2-cell contracting for 2027 held back and some 2027 volume moved to 2028; a 2027-2029 backlog and pipeline of 22.8 GW; 2026 production narrowed to 4.0-4.2 GW. Questions from Roth, BTIG, Needham and Vertical Research
    assuming we're doing financial close by year-end, we would expect to finish construction, installation, commissioning and ramping by about midyear.
    backsC17C39C60
  40. S40primarycompany filing2026-11-12
    one customer at about 99% of nine-month net sales; the going-concern basis resting on cash, operations, 45X monetisation and new debt or equity; warrants for up to 500,000 shares at $0.01 issued on 29 October with commercial contracts; 300,601,542 shares at 9 November
    backsC60
  41. S41primarycompany filing2026-11-12
    the SEC Fort Worth office's investigation, opened in September 2026, into T1's disclosures on its 45X eligibility and other accounting matters; the DOJ subpoenas and SEC document request of late 2025 repeated, with T1 cooperating
    In September 2026, the Fort Worth Regional Office of the United States Securities and Exchange Commission informed the Company that it is conducting an investigation into T1's public disclosures related to its eligibility for 45X Tax Credits and certain other accounting matters.
    backsC32C62
Rendered from content/TE/thesis.json · thesis reviewed 2026-11-13. This page explains a company; it does not say what to pay, when to buy or how much.